title: Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis.
abstract: The objective of the study is to evaluate the effect of TNF inhibition on carotid thickness over a 2-year period. 144 women with RA diagnosed according to ACR criteria, without clinical evidence of cardiac and/or vascular disease were enrolled and compared with 78 matched controls. All patients received methotrexate (15–20 mg weekly) for 3 months. Responders (n = 79) continued to be treated with methotrexate, non-responders (n = 40) moved to methotrexate plus a TNF alpha antagonist. Echosonographic studies of carotids were obtained before and after 2-year follow-up. A significant decrease of ca-IMT was observed in anti-TNF-treated patients (P < 0.001); on the other hand, no significant variation of ca-IMT was observed after 2 years in MTX-treated patients. Our study indicates that anti-TNF blocking agents, but not methotrexate, are capable of reducing IMT of carotid arteries in female RA patients in a 2-year follow-up.
authors.affiliation: Division of Rheumatology, Department of Internal Medicine, University of Palermo, Palermo, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Ferrante
authors.forename: A R
authors.initials: AR
authors.lastname: Giardina
authors.forename: F
authors.initials: F
authors.lastname: Ciccia
authors.forename: G
authors.initials: G
authors.lastname: Parrinello
authors.forename: G
authors.initials: G
authors.lastname: Licata
authors.forename: G
authors.initials: G
authors.lastname: Avellone
authors.forename: E
authors.initials: E
authors.lastname: Giardina
authors.forename: R
authors.initials: R
authors.lastname: Impastato
authors.forename: Giovanni
authors.initials: G
authors.lastname: Triolo
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002340:Carotid Artery Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D017539:Tunica Intima / Q000187:drug effects*; D017540:Tunica Media / Q000187:drug effects*; D014463:Ultrasonography
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D008727:Methotrexate